Please login to the form below

Not currently logged in
Email:
Password:

Verona Pharma

This page shows the latest Verona Pharma news and features for those working in and with pharma, biotech and healthcare.

Vernalis accepts £33m takeover offer from Ligand Pharma

Vernalis accepts £33m takeover offer from Ligand Pharma

Vernalis accepts £33m takeover offer from Ligand Pharma. After mulling over several takeover offers, UK biotech Vernalis has been won over by an overture from California’s Ligand Pharma that values ... Clinical-stage pipeline projects include Verona

Latest news

  • Verona Pharma appoints Dr Sven Jan-Anders Karlsson as CEO

    Verona Pharma appoints Dr Sven Jan-Anders Karlsson as CEO. He takes over from the UK biotech company's co-founder Michael Walker. ... Verona Pharma has appointed Dr Sven Jan-Anders Karlsson to be the respiratory-focused biotech's new CEO.

  • The power of small

    Putting his money where his mouth is, Trevor joined Verona Pharma, a small, start-up biotech, as non-executive director of the board in September 2006. ... The Author. Michael Walker, PhD is chief executive officer and co-founder of Verona Pharma.

  • Malcolm's Market Eye: 6 to 12 October 2007

    Verona Pharma may have secured go ahead for chronic respiratory drug. ... Verona Pharma, the life sciences company, is focusing on therapeutic drugs with which to treat asthma, hay- fever and other chronic respiratory ailments.

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Dr Desiree Luthman joins Verona Pharma Dr Desiree Luthman joins Verona Pharma

    Dr Desiree Luthman joins Verona Pharma. She takes up its vice president position. ... Jan-Anders Karlsson, chief executive officer of Verona Pharma, said: “We welcome Desiree to our growing pharma team.

  • Verona Pharma strengthens senior management team Verona Pharma strengthens senior management team

    Verona Pharma has appointed Richard Hennings in a role that will see him oversee the firm’s marketing access strategy and increase its commercial focus. ... Jan-Anders Karlsson, CEO of Verona Pharma, said: “We are delighted to welcome Richard to the

  • Mereo BioPharma’s Richard Bungay to step down Mereo BioPharma’s Richard Bungay to step down

    He has previously held the chief financial title at Glide Pharmaceutical Technologies, Chroma Therapeutics and Verona Pharma, remaining as a non-executive board director at both Glide and Chroma.

  • Vikas Sinha joins Verona as non-executive director Vikas Sinha joins Verona as non-executive director

    UK drug development company Verona Pharma has appointed Vikas Sinha as a non-executive director. ... Dr David Ebsworth, chairman of Verona Pharma, said: “ Vikas' impressive financial background, including his US expertise, makes him a very welcome

  • Verona names David Ebsworth as non-executive chairman Verona names David Ebsworth as non-executive chairman

    Verona Pharma has appointed Dr David Ebsworth as its non-executive chairman of the board of directors. ... David' significant expertise in the pharma industry strongly supports Verona Pharma's focus on high value commercial opportunities and future growth

More from appointments
Approximately 4 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics